The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 19, 2023

Filed:

Oct. 15, 2018
Applicants:

Nibec Co., Ltd., Chungcheongbuk-do, KR;

Chungbuk National University Industry Academic Cooperation Foundation, Chungcheongbuk-do, KR;

Seoul National University R&db Foundation, Seoul, KR;

Inventors:

Yoon Shin Park, Chungcheongbuk-do, KR;

Yoon Jeong Park, Seoul, KR;

Chong-Pyoung Chung, Seoul, KR;

Jue-Yeon Lee, Gyeonggi-do, KR;

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/10 (2006.01); G01N 33/53 (2006.01); G01N 33/58 (2006.01); G01N 33/68 (2006.01); C07K 7/08 (2006.01); C07K 9/00 (2006.01); C07K 16/18 (2006.01); G01N 33/50 (2006.01);
U.S. Cl.
CPC ...
C07K 16/18 (2013.01); A61K 38/10 (2013.01); C07K 7/08 (2013.01); C07K 9/00 (2013.01); G01N 33/5073 (2013.01); G01N 33/53 (2013.01); G01N 33/582 (2013.01); G01N 33/68 (2013.01); C07K 2319/00 (2013.01); C07K 2319/40 (2013.01); C07K 2319/60 (2013.01);
Abstract

The present invention relates to a GRP78-derived peptide for screening highly efficient stem cells and the use thereof, and more particularly, to screening highly efficient stem cells using, as a marker, a GRP78-derived peptide capable of binding to the binding domain of GRP78 protein on the cell surface. According to the present invention, the GRP78-derived peptide comprising only a specific amino acid sequence capable of recognizing highly efficient stem cells, among the amino acid sequence of GRP78, makes it possible to screen only non-senescent young stem cells. In addition, when stem cells are treated with the GRP78-derived peptide or the GRP78-derived peptide is introduced into stem cells, the efficiency of the stem cells can be increased. Thus, the GRP78-derived peptide is useful for the production of stem cell therapy products having excellent efficacy.


Find Patent Forward Citations

Loading…